Literature DB >> 21039029

Disability adjusted life years for cancer patients in India.

Nandagudi Srinivasa Murthy1, B S Nandakumar, Sreekantaiah Pruthvish, Preethi Sara George, Aleyamma Mathew.   

Abstract

The disability adjusted life year (DALY) has been employed to quantify the burden of diseases. This measure allows for combining in a single indicator "years of life lived with disabilities (YLD)" and "years of life lost from premature death (YLL)" . The present communication attempts to estimate the burden of cancers in-terms of YLL, YLD and DALY for "all sites" and leading sites of cancer in India for the years 2001, 2006, 2011 and 2016. The YLL, YLD and DALY were estimated by employing Global Burden of Disease (GBD) methodology using the DISMOD procedure. The published data on age, gender and site specific cancer incidence and mortality for the years 2001-2003 relating to six population-based cancer registries viz. Bangalore, Barshi, Bhopal, Chennai, Delhi and Mumbai, expectation of life by gender for urban areas of the country for 1999-2003 and the projected population during years 2001, 2006, 2011 and 2016 were utilized for the computations. DALYs were found to be lower for males (2,038,553, 2,313,843, 2,656,693 and 3,021,708 for 2001, 2006, 2011 and 2016 respectively) as compared to females (2,560,423, 2,961,218, 3,403,176 and 3,882,649). Amongst males, highest DALYs were contributed by cancer of the lung and esophagus while in females they were for cancers of breast and cervix uteri. It is estimated that total DALYs due to cancer in India combined for both genders would increase from 4,598,976 in 2001 to 6,904,358 by 2016. Premature mortality is a major contributor to disease burden. According to the present estimates, the YLL component of DALY is about 70.0%. The above described computations reveal an urgent need for initiating primary and secondary prevention measures for control of cancers.

Entities:  

Mesh:

Year:  2010        PMID: 21039029

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  12 in total

1.  Cluster of Differentiation 44 (CD44) Gene Variants: A Putative Cancer Stem Cell Marker in Risk Prediction of Bladder Cancer in North Indian Population.

Authors:  Archana Verma; Rakesh Kapoor; Rama Devi Mittal
Journal:  Indian J Clin Biochem       Date:  2016-05-21

2.  Genetic Variation in CD166 Gene and Its Association with Bladder Cancer Risk in North Indian Population.

Authors:  Archana Verma; Rakesh Kapoor; Rama Devi Mittal
Journal:  Indian J Clin Biochem       Date:  2016-08-26

3.  A comparison of behavioural models explaining cervical cancer screening uptake.

Authors:  Jyoshma Preema Dsouza; Stephan Van den Broucke; Sanjay Pattanshetty; William Dhoore
Journal:  BMC Womens Health       Date:  2022-06-16       Impact factor: 2.742

4.  Competing Risk Approach (CRA) for Estimation of Disability Adjusted Life Years (DALY's) for Female Breast Cancer in India.

Authors:  Radhika Kunnavil; Chethana Thirthahalli; Shalini Chandrashekar Nooyi; N S Shivaraj; Nandagudi Srinivasa Murthy
Journal:  J Clin Diagn Res       Date:  2015-10-01

5.  Burden of disease resulting from chronic mountain sickness among young Chinese male immigrants in Tibet.

Authors:  Tao Pei; Xiaoxiao Li; Fasheng Tao; Haotong Xu; Haiyan You; Linlin Zhou; Yan Liu; Yuqi Gao
Journal:  BMC Public Health       Date:  2012-06-06       Impact factor: 3.295

6.  Systematic literature review to evaluate and characterize the health economics and outcomes research studies in India.

Authors:  Divya Mishra; Sunita R Nair
Journal:  Perspect Clin Res       Date:  2015 Jan-Mar

7.  Application of disability-adjusted life years to predict the burden of injuries and fatalities due to public exposure to engineering technologies.

Authors:  Arun Veeramany; Srikanth Mangalam
Journal:  Popul Health Metr       Date:  2014-03-28

8.  Burden of breast and gynecological cancers in Tunisia between 1990 and 2030: Trend and projection.

Authors:  Sonia Dhaouadi; Amal Cherif; Hajer Hannachi; Molka Osman; Mohamed Hsairi
Journal:  Tunis Med       Date:  2021 Avril

9.  Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer.

Authors:  Isabelle Soerjomataram; Joannie Lortet-Tieulent; Jacques Ferlay; David Forman; Colin Mathers; D Maxwell Parkin; Freddie Bray
Journal:  BMC Med Res Methodol       Date:  2012-08-17       Impact factor: 4.615

10.  Estimating the lifelong health impact and financial burdens of different types of lung cancer.

Authors:  Szu-Chun Yang; Wu-Wei Lai; Wu-Chou Su; Shang-Yin Wu; Helen H W Chen; Yi-Lin Wu; Mei-Chuan Hung; Jung-Der Wang
Journal:  BMC Cancer       Date:  2013-12-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.